By Jennifer Chiou
New York, Nov. 29 - Guava Technologies, Inc. said it obtained $7 million in private venture financing.
Investors included Abingworth Life Science Investment, Granite Global Ventures, HLM Venture Partners, MDS Capital Corp., ProQuest Investments and Skyline Ventures.
"The growth of our programs is accelerating at a pace we believe will make Guava Technologies cash flow positive within 12 months," Guava chief executive officer Larry Bruder said in a news release.
"This growth stems from new product introductions, sales to new customer bases within the overall cell analysis market and penetration of foreign markets as well. The current financing will enable us to continue our growth initiative, bringing us more rapidly to self sufficiency."
Guava Technologies, a Hayward, Calif., biotechnology and medical device company, provides cell analysis systems.
| Issuer: | Guava Technologies, Inc.
|
| Issue: | Stock
|
| Amount: | $7 million
|
| Investors: | Abingworth Life Science Investment, Granite Global Ventures, HLM Venture Partners, MDS Capital Corp., ProQuest Investments, Skyline Ventures
|
| Announcement date: | Nov. 29
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
